期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022; 20 (4)
Objectives To derive the population norms for EQ-5D-5L and SF-6Dv2 among the Chinese general population. Methods Data collected alongside the Chinese ......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022; 20 (3)
Background Assessing the public's willingness to pay (WTP) for the coronavirus disease 2019 (COVID-19) vaccine by the contingent valuation (CV) method......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022; 20 (3)
Background and objective Osteoarthritis (OA) is a highly prevalent, disabling disease requiring chronic management that is associated with an enormous......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022; 20 (6)
Objective The aim of this study was to estimate the population's willingness to pay (WTP) for an additional quality-adjusted life-year (QALY) in China......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022; 20 (5)
Background Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic respiratory disease with considerable clinical and socioeconomic......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022; 20 (1)
Objective Our objective was to assess the incidence and quality of reporting of published health economic evaluations in mainland China and compare th......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020; 18 (5)
The concept of a Health Promoting School has been found to be effective to improve health and well-being of students as well as a help with teaching a......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2019; 17 (2)
BackgroundAs the largest developing country in the world, China is still on its way towards building an adequate system of health insurance through co......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 0; ()
Background Inappropriate prescribing is an important health system problem in China. Several studies have identified critical factors influencing pres......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018; 16 (1)
The aim of this article is to describe the process, evaluation criteria, and possible outcomes of decision-making for new drugs listed in the Hong Kon......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018; 16 (5)
Health-related quality-of-life (HRQoL) measures are commonly mapped to a value that represents a utility for economic evaluation via regression models......
期刊： APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2017; 15 (1)
Background The low availability of essential medicines is a worldwide issue of concern. In 2009, China introduced a National Essential Medicines List ......
